 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2013, vol. 19, book 3;
Subject Collection: Medicine
Page: 438-441
DOI: 10.5272/jimab.2013193.438
Published online: 22 July 2013
J of IMAB. 2013 Jul-Dec;19(3):438-441;
A CASE STUDY OF BRAIN VOLUME REDUCTION IN MULTIPLE SCLEROSIS
Ivan N. Dimitrov 1
, Ara G. Kaprelyan, Borislav Ivanov,
First Clinic of Neurology, "St. Marina" University Hospital, Varna, Bulgaria.
ABSTRACT:
The development of sophisticated magnetic resonance imaging techniques and software for medical imaging processing and analysis has led to a significant progress in multiple sclerosis research and clinical care. The measurement of brain volumes provides a quantitative representation of damage, thus facilitating the objective follow-up process. The parameters obtained, though not being used routinely in clinical practice, are more and more often applied in clinical studies. The amount of whole brain and regional atrophy, estimated from serial scans, is considered important not only for disease progression, but also for cognitive dysfunction which is common in multiple sclerosis. In this paper we describe a volumetric study of two magnetic resonance scans of a patient with relapsing-remitting multiple sclerosis, performed 16 months one after the other, and analyzed using FSL SIENA software. Analysis demonstrated brain volume reduction of 1.7% between the two scans. We discuss the advantages of the method and its possible clinical applications.
Key words: Brain Volume; Brain Atrophy; Magnetic Resonance Imaging (MRI); Multiple Sclerosis;
- Download FULL TEXT /PDF 849 KB/
Please cite this article as:
Dimitrov IN, Kaprelyan AG, Ivanov B. A Case Study of Brain Volume Reduction in Multiple Sclerosis. J of IMAB. 2013 Jul-Dec;19(3):438-441. DOI: 10.5272/jimab.2013193.438.
Correspondence to: Ivan N. Dimitrov, MD, PhD, First Clinic of Neurology, “Sveta Marina“ University Hospital; 1 Hristo Smirnenski str., 9010 Varna, Bulgaria; e-mail: indimitrov@mail.bg;
1. Grassiot B, Desgranges B, Eustache F, Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol. 2009 Sep;256(9):1397-1412. [PubMed] [CrossRef]
2. Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, et al. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging. 2007 Apr;17(Suppl 1):16S-21S. [PubMed] [CrossRef]
3. Broderick JP, Narayan S, Gaskill M, Dhawan AP, Khoury J. Volumetric measurement of multifocal brain lesions. Implications for treatment trials of vascular dementia and multiple sclerosis. J Neuroimaging. 1996 Jan;6(1):36-43. [PubMed]
4. Filippi M, Comi G, Rovaris M, eds. Normal-appearing White and Grey Matter Damage in Multiple Sclerosis. Springer Milan; 2004. [CrossRef]
5. Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 2009 Sep;66(9):1144-1150. [PubMed] [CrossRef]
6. Giorgio A, Santelli L, Tomassini V, Bosnell R, Smith S, De Stefano N, et al. Age-related changes in grey and white matter structure throughout adulthood. Neuroimage. 2010 Jul 1;51(3):943-951. [PMC free article] [CrossRef]
7. Raz E, Cercignani M, Sbardella E, Totaro P, Pozzilli C, Bozzali M, et al. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology. 2010 Jan;254(1):227-234. [CrossRef]
8. Pelletier D, Garrison K, Henry R. Measurement of whole-brain atrophy in multiple sclerosis. J Neuroimaging. 2004 Jul;14(3 Suppl):11S-19S. [PubMed]
9. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002 Sep;17(1):479-489. [PubMed] [CrossRef]
10. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004; 23(Suppl 1):S208-219. [PubMed] [CrossRef]
11. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011 Feb;69(2):292-302. [PubMed] [CrossRef]
12. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002 Jun;15(3):239-245. [PubMed]
13. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, Ying J, et al. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage. 2011 Jan 15;54(2):802-806. [PubMed] [CrossRef].
Accepted for publication: 16 April 2013
Published online: 22 July 2013